Emerging Role of Imaging in Cardiovascular Theranostics (Virtual Event)

Albert J. Sinusas, M.D.

Professor of Medicine, Radiology & Biomedical Imaging, and Biomedical Engineering
Yale University School of Medicine

Albert J. Sinusas, M.D., FACC, FAHA, FASNC is Professor of Medicine (Section of Cardiovascular Medicine) and Radiology and Biomedical Imaging, Yale University School of Medicine, Professor of Biomedical Engineering, Yale University, and Director of the Yale Translational Research Imaging Center (Y-TRIC), and Director of Advanced Cardiovascular Imaging at Yale New Haven Hospital. He received a BS degree at Rensselaer Polytechnic Institute, MD degree at University of Vermont, College of Medicine, and completed training in internal medicine at the University of Oklahoma, and training in cardiology and nuclear cardiology at the University of Virginia. He joined the faculty at Yale University School of Medicine in 1990 where he has remained. Dr. Sinusas has served as a standing member of the Clinical and Integrated Cardiovascular Sciences (CICS), and standing member and chair of Medical Imaging (MEDI), and Clinical Translational Imaging Sciences (CTIS) study sections of the National Institutes of Health. Dr. Sinusas has been a member of the Board of Directors of the Cardiovascular Council (CVC), Molecular Imaging Center of Excellence (MICoE), and Center for Molecular Imaging Innovation and Translation (CMIIT) of the Society of Nuclear Medicine (SNM), and Board of Directors of the American Society of Nuclear Cardiology. He was the 2008 recipient of the SNMMI Hermann Blumgart Award. His research is directed at development, validation and application of non-invasive cardiovascular imaging approaches for the assessment of cardiovascular pathophysiology, including the targeted molecular assessment of myocardial ischemic injury, angiogenesis, arteriogenesis, and post–infarction atrial and ventricular remodeling, and peripheral artery disease. The investigation of these biological processes involves, ex vivo and in vivo imaging in animal models of cardiovascular disease and humans. This translational research employs the 3–D modalities of X-ray computed tomography (CT) and fluoroscopy, SPECT/CT, PET/CT, echocardiography, and MR imaging in an animal physiology laboratory and clinical environment. Dr. Sinusas is the principal investigator of several NIH grants involving multi-modality cardiovascular imaging, and directs a NIH funded T32 grant providing training in multi-modality molecular and translational cardiovascular imaging. He is the author of over 250 peer reviewed publications and invited reviews related to cardiovascular imaging, and co-edited a textbook entitled Cardiovascular Molecular Imaging published in 2007 and Hybrid Imaging in Cardiovascular Medicine in 2018.

Join Meeting!

Dr. Sinusas’ Objectives

• Examine the role of multi-modality imaging for evaluation of cardiovascular disease
• Appraise the potential of targeted molecular imaging for guiding personalized patient care
• Evaluate the emerging role of theranostic in management of cardiovascular disease

Faculty Disclosures

Dr. Sinusas has indicated the following relevant financial relationships with commercial interests:
Financial Relationship                                     Commercial Interest/Organization
Research                                                             Jubilant, Siemens

Planning Committee Disclosure

Dr. Deshpande has indicated that he has no relevant financial relationships with commercial interests.

Dr. Weiss has indicated the following relevant financial relationships with commercial interests:
Financial Relationship                                     Commercial Interest/Organization
Consultant/Contractor                                           Prizm LLC

All the relevant financial relationships for these individuals have been mitigated.

Target Audience
Primary care physicians.

Accreditation
The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.